Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Cobalt Chloride Induces Necroptosis in Human Colon Cancer HT-29 Cells

  • Wang, Hai-Yu (Department of General Surgery, Zhongshan hospital, Fudan University) ;
  • Zhang, Bo (Department of General Surgery, Zhongshan hospital, Fudan University)
  • Published : 2015.04.03
Download PDF
⟨ Previous Next ⟩

Abstract

Necroptosis, also known as "programmed necrosis", has emerged as a critical factor in a variety of pathological and physiological processes and is considered a cell type-specific tightly regulated process with mechanisms that may vary rather greatly due to the change of cell line. Here we used HT-29, a human colon cancer cell line, to establish a necroptosis model and elucidate associated mechanisms. We discovered that cobalt chloride, a reagent that could induce hypoxia-inducible $factor-1{\alpha}(HIF1{\alpha})$ expression and therefore mimic the hypoxic microenvironment of tumor tissue in some aspects induces necroptosis in HT-29 cells when caspase activity is compromised. On the other hand, apoptosis appears to be the predominant death form when caspases are functioning normally. HT-29 cells demonstrated significantly increased RIPK1, RIPK3 and MLKL expression in response to cobalt chloride plus z-VAD treatment, which was accompanied by drastically increased $IL1{\alpha}$ and IL6 expression, substantiating the notion that necrosis can induce profound immune reactions. The RIPK1 kinase inhibitor necrostatin-1 and the ROS scavenger NAC each could prevent necrosis in HT-29 cells and the efficiency was enhanced by combined treatment. Thus by building up a necroptosis model in human colon cancer cells, we uncovered that mechanically RIP kinases collaborate with ROS during necrosis promoted by cobalt chloride plus z-VAD, which leads to inflammation. Necroptosis may present a new target for therapeutic intervention in cancer cells that are resistant to apoptotic cell death.

Keywords

References

  1. Cho YS, Challa S, Moquin D, et al (2009). Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell, 137, 1112-23. https://doi.org/10.1016/j.cell.2009.05.037
  2. de Bruin EC, Medema JP (2008). Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev, 34, 737-49. https://doi.org/10.1016/j.ctrv.2008.07.001
  3. Duprez L, Takahashi N, Van Hauwermeiren F, et al (2011). RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity, 35, 908-18. https://doi.org/10.1016/j.immuni.2011.09.020
  4. Fu D, Jordan JJ, Samson LD (2013). Human ALKBH7 is required for alkylation and oxidation-induced programmed necrosis. Genes Dev, 27, 1089-1100. https://doi.org/10.1101/gad.215533.113
  5. Green DR, Oberst A, Dillon CP, et al (2011). RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol Cell, 44, 9-16. https://doi.org/10.1016/j.molcel.2011.09.003
  6. He S, Wang L, Miao L, et al (2009). Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell, 137, 1100-11. https://doi.org/10.1016/j.cell.2009.05.021
  7. Junttila MR, de Sauvage FJ (2013). Influence of tumour micro-environment heterogeneity on therapeutic response. Nature, 501, 346-54. https://doi.org/10.1038/nature12626
  8. Kaczmarek A, Vandenabeele P, Krysko DV (2013). Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity, 38, 209-223. https://doi.org/10.1016/j.immuni.2013.02.003
  9. Krysko DV, Garg AD, Kaczmarek A, et al (2012). Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer, 12, 860-75. https://doi.org/10.1038/nrc3380
  10. Krysko DV, Vandenabeele P (2008). From regulation of dying cell engulfment to development of anti-cancer therapy. Cell Death Differ, 15, 29-38. https://doi.org/10.1038/sj.cdd.4402271
  11. Ku G, Tan IB, Yau T, et al (2012). Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol, 13, 470-481. https://doi.org/10.1016/S1470-2045(12)70424-2
  12. ME P. (2011). Programmed cell death: Apoptosis meets necrosis. Nature, 471, 310-2. https://doi.org/10.1038/471310a
  13. Motz GT, Coukos G (2013). Deciphering and reversing tumor immune suppression. Immunity, 39, 61-73. https://doi.org/10.1016/j.immuni.2013.07.005
  14. Narayan N, Lee IH, Borenstein R, et al (2012). The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature, 492, 199-204. https://doi.org/10.1038/nature11700
  15. Oberst A, Dillon CP, Weinlich R, et al (2011). Catalytic activity of the caspase-8-FLIP (L) complex inhibits RIPK3-dependent necrosis. Nature, 471, 363-7. https://doi.org/10.1038/nature09852
  16. Saddoughi SA, Gencer S, Peterson YK, et al (2013). Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med, 5, 105-121. https://doi.org/10.1002/emmm.201201283
  17. Saeidnia S, Abdollahi M (2013). Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century. Toxicol Appl Pharm, 271, 49-63. https://doi.org/10.1016/j.taap.2013.05.004
  18. Sakurai T, He G, Matsuzawa A, et al (2008). Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell, 14, 156-65. https://doi.org/10.1016/j.ccr.2008.06.016
  19. Sosa V, Moline T, Somoza R, et al (2013). Oxidative stress and cancer: an overview. Ageing Res Rev, 12, 376-90. https://doi.org/10.1016/j.arr.2012.10.004
  20. Sun L, Wang H, Wang Z, et al (2012). Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell, 148, 213-27. https://doi.org/10.1016/j.cell.2011.11.031
  21. Trachootham D, Alexandre J, Huang P (2009). Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov, 8, 579-91. https://doi.org/10.1038/nrd2803
  22. Tu HC, Ren D, Wang GX, et al (2009). The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage. Proc Natl Acad Sci USA, 106, 1093-8. https://doi.org/10.1073/pnas.0808173106
  23. Ullrich E, Bonmort M, Mignot G, et al (2008). Tumor stress, cell death and the ensuing immune response. Cell Death Differ, 15, 21-8. https://doi.org/10.1038/sj.cdd.4402266
  24. Wang L, Du F, Wang X (2008). TNF-alpha induces two distinct caspase-8 activation pathways. Cell, 133, 693-703. https://doi.org/10.1016/j.cell.2008.03.036
  25. Welz PS, Wullaert A, Vlantis K, et al (2011). FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature, 477, 330-4. https://doi.org/10.1038/nature10273
  26. Whelan RS KK, Wei AC, Chen Y, et al (2012). Bax regulates primary necrosis through mitochondrial dynamics. Proc Natl Acad Sci USA, 109, 6566-71. https://doi.org/10.1073/pnas.1201608109
  27. Zhang H, Zhou X, McQuade T, et al (2011). Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature, 471, 373-6. https://doi.org/10.1038/nature09878
  28. Zheng Y, Humphry M, Maguire JJ, et al (2013). Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1alpha, controlling necrosis-induced sterile inflammation. Immunity, 38, 285-95. https://doi.org/10.1016/j.immuni.2013.01.008
  29. Zou W, Xu W, Huo H, et al (2001). Cobalt chloride induces PC12 cells apoptosis through reactive oxygen species and accompanied by AP-1 activation. J Neurosci Res, 64, 646-53. https://doi.org/10.1002/jnr.1118

Cited by

  1. Shikonin Induced Necroptosis via Reactive Oxygen Species in the T-47D Breast Cancer Cell Line vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7261
  2. Cell Death Conversion under Hypoxic Condition in Tumor Development and Therapy vol.16, pp.10, 2015, https://doi.org/10.3390/ijms161025536